This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Antitrust Europe | 9 Aug 2021

( August 9, 2021, 07:33 GMT | Press Round-Up Europe) -- Contents: - UK PCR costs need CMA scrutiny, health minister says - Axa’s dominance of French mass-transit insurance criticized - Philip Morris raises offer in Vectura bidding war - Poste Italiane fined EUR10 million for market abuse - TAP airline restructuring raises concerns in Brussels - Veoneer open to Qualcomm’s takeover offer - Canal Plus ordered to broadcast French football - Siemens, Everis to develop cross-mode platform for Renfe - Carlyle set to acquire traffic-tech specialist Schaltbau - Moody’s buys climate-risk specialist RMS for $2 billion- UK health minister Sajid Javid has asked the Competition and Markets Authority to investigate firms that are selling PCR tests at "excessive" prices and engaging in "exploitative practices." Javid has written to the CMA to call for a high-level review, in a bid to protect holidaymakers requiring private PCR tests before and after travel....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login